Most Popular

India: Everstone Capital invests close to US$270m for a substantial stake in the Apothecon Group

Singapore-based private equity firm Everstone Capital has partnered with the founding promoters of India-based Apothecon and US-based Navinta, investing close to US$270m for a substantial stake in the Apothecon Group. The combined platform is a regulated markets-focused, speciality formulations business with in-house formulations and captive API manufacturing, as well...

The new space race: zero gravity drug development

Space is rapidly evolving from a theatre of exploration into a platform for high‑value industries, such as pharmaceuticals. As in‑orbit manufacturing becomes more technically and commercially viable, it is opening new frontiers in drug development and raising important questions around intellectual property, value creation and competitive advantage, writes Paul Bettridge, IP partner at European intellectual property firm Carpmaels & Ransford. History was made this month when humans travelled further from Earth than ever before aboard Orion Integrity on the Artemis II mission. The flight captured headlines and imaginations, but the...